Paul Tudor Jones Applied Therapeutics Inc. Transaction History
Tudor Investment Corp Et Al
- $44 Billion
- Q2 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 57,454 shares of APLT stock, worth $66,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,454
Previous 57,454
-0.0%
Holding current value
$66,072
Previous $28,000
39.29%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
78Shares Held
89.6MCall Options Held
152KPut Options Held
186K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.7MShares$21.5 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY11.5MShares$13.2 Million0.19% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$13 Million4.26% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$8.97 Million1.64% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$7.56 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $55.2M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...